Literature DB >> 25736166

Cortical thinning and progressive cortical porosity in female patients with systemic lupus erythematosus on long-term glucocorticoids: a 2-year case-control study.

T Y Zhu1,2, J F Griffith3, L Qin2, V W Y Hung2, T-N Fong2, S-K Au4, X-L Tang1, E W Kun5, A W Kwok4, P-C Leung4, E K Li1, L-S Tam6,7.   

Abstract

UNLABELLED: In this study, we characterized longitudinal changes of volumetric bone mineral density and cortical and trabecular microstructure at the distal radius using HR-pQCT in female systemic lupus erythematosus (SLE) patients on long-term glucocorticoids. Cortical thinning and increased cortical porosity are the major features of longitudinal microstructural deterioration in SLE patients.
INTRODUCTION: The study aims to characterize longitudinal changes of volumetric bone mineral density (vBMD) and bone microstructure at distal radius in female systemic lupus erythematosus (SLE) patients on long-term glucocorticoids.
METHODS: This 2-year case-control study consisted of 166 premenopausal subjects (75 SLE patients and 91 controls) and 79 postmenopausal subjects (44 SLE patients and 35 controls). We obtained areal BMD (aBMD) by dual-energy X-ray absorptiometry at multiple skeletal sites and indices of vBMD and microstructure at distal radius by high-resolution peripheral quantitative computed tomography (HR-pQCT) at baseline, 12 and 24 months.
RESULTS: In either premenopausal or postmenopausal subjects, changes in aBMD did not differ between patients and controls except that decrease in aBMD at total hip at 24 months in premenopausal patients was significantly higher. In premenopausal subjects, decrease in cortical area (-0.51 vs. -0.06 %, p = 0.039) and thickness (-0.63 vs. 0.02 %, p = 0.031) and increase in cortical porosity (21.7 vs. 7.16 %, p = 0.030) over study period were significantly larger in patients after adjustment of age and body mass index. Decreased in trabecular vBMD was significantly less (-0.63 vs. -2.32 %, p = 0.001) with trabecular microstructure better maintained in patients. In postmenopausal subjects, decrease in cortical vBMD (-2.66 vs. -1.56 %, p = 0.039) and increase in cortical porosity (41.6 vs. 16.3 %, p = 0.021) were significantly higher in patients, and there was no group-wise difference in change of trabecular microstructure.
CONCLUSION: Longitudinal microstructural deterioration in SLE is characterized by cortical thinning and increased cortical porosity. Cortical bone is an important source of bone loss in SLE patients on glucocorticoids.

Entities:  

Keywords:  Bone microstructure; Glucocorticoids; HR-pQCT; Osteoporosis; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2015        PMID: 25736166     DOI: 10.1007/s00198-015-3077-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  42 in total

Review 1.  Osteoporosis and fractures in systemic lupus erythematosus.

Authors:  Irene E M Bultink
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-01       Impact factor: 4.794

2.  In vivo determination of bone structure in postmenopausal women: a comparison of HR-pQCT and high-field MR imaging.

Authors:  Galateia J Kazakia; Benedict Hyun; Andrew J Burghardt; Roland Krug; David C Newitt; Anne E de Papp; Thomas M Link; Sharmila Majumdar
Journal:  J Bone Miner Res       Date:  2008-04       Impact factor: 6.741

3.  Bone microarchitecture assessment by high-resolution peripheral quantitative computed tomography in patients with systemic lupus erythematosus taking corticosteroids.

Authors:  Edmund K Li; Tracy Y Zhu; Lai-Shan Tam; Vivian W Hung; James F Griffith; Tena K Li; Martin Li; Kong Chiu Wong; Ping Chung Leung; Anthony W Kwok; Ling Qin
Journal:  J Rheumatol       Date:  2010-05-15       Impact factor: 4.666

4.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

5.  Bone mineral density change in systemic lupus erythematosus: a 5-year followup study.

Authors:  Tracy Y Zhu; James F Griffith; Sze-Ki Au; Xiao-Lin Tang; Anthony W Kwok; Ping-Chung Leung; Edmund K Li; Lai-Shan Tam
Journal:  J Rheumatol       Date:  2014-07-01       Impact factor: 4.666

6.  Increased organ damage associated with deterioration in volumetric bone density and bone microarchitecture in patients with systemic lupus erythematosus on longterm glucocorticoid therapy.

Authors:  Xiao Lin Tang; Tracy Yaner Zhu; Vivian W Hung; Ling Qin; Chun-Kwok Wong; Emily W Kun; Lai Shan Tam; Edmund K Li
Journal:  J Rheumatol       Date:  2012-08-15       Impact factor: 4.666

7.  Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate.

Authors:  Ego Seeman; Pierre D Delmas; David A Hanley; Deborah Sellmeyer; Angela M Cheung; Elizabeth Shane; Ann Kearns; Thierry Thomas; Steven K Boyd; Stephanie Boutroy; Cesar Bogado; Sharmila Majumdar; Michelle Fan; Cesar Libanati; Jose Zanchetta
Journal:  J Bone Miner Res       Date:  2010-08       Impact factor: 6.741

8.  Longitudinal analysis of bone mineral density in pre-menopausal female systemic lupus erythematosus patients: deleterious role of glucocorticoid therapy at the lumbar spine.

Authors:  D Jardinet; C Lefèbvre; G Depresseux; M Lambert; J P Devogelaer; F A Houssiau
Journal:  Rheumatology (Oxford)       Date:  2000-04       Impact factor: 7.580

9.  Autoantibodies closely relate to the elevation level of in vivo hydrogen peroxide and tissue damage in systemic lupus erythematosus.

Authors:  Yongquan Wang; Bin Qiao; Ying Wang; Xiaohui Han; Yiwei Chu; Sidong Xiong
Journal:  DNA Cell Biol       Date:  2006-10       Impact factor: 3.311

10.  Bone loss and bone size after menopause.

Authors:  Henrik G Ahlborg; Olof Johnell; Charles H Turner; Gunnar Rannevik; Magnus K Karlsson
Journal:  N Engl J Med       Date:  2003-07-24       Impact factor: 91.245

View more
  8 in total

1.  Distal radius and tibia bone microarchitecture impairment in female patients with diffuse systemic sclerosis.

Authors:  M M Sampaio-Barros; J C Alvarenga; L Takayama; A P L Assad; P D Sampaio-Barros; R M R Pereira
Journal:  Osteoporos Int       Date:  2019-04-27       Impact factor: 4.507

Review 2.  Bone quality changes associated with aging and disease: a review.

Authors:  Adele L Boskey; Laurianne Imbert
Journal:  Ann N Y Acad Sci       Date:  2017-12       Impact factor: 5.691

Review 3.  Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club.

Authors:  Michaël R Laurent; Stefan Goemaere; Charlotte Verroken; Pierre Bergmann; Jean-Jacques Body; Olivier Bruyère; Etienne Cavalier; Serge Rozenberg; Bruno Lapauw; Evelien Gielen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

4.  Clinical and Radiological Characterization of Patients with Immobilizing and Progressive Stress Fractures in Methotrexate Osteopathy.

Authors:  Tim Rolvien; Nico Maximilian Jandl; Julian Stürznickel; Frank Timo Beil; Ina Kötter; Ralf Oheim; Ansgar W Lohse; Florian Barvencik; Michael Amling
Journal:  Calcif Tissue Int       Date:  2020-10-16       Impact factor: 4.333

Review 5.  Dilemmas in the Management of Osteoporosis in Younger Adults.

Authors:  Madhuni Herath; Adi Cohen; Peter R Ebeling; Frances Milat
Journal:  JBMR Plus       Date:  2022-01-19

Review 6.  Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus.

Authors:  Irene E M Bultink
Journal:  Calcif Tissue Int       Date:  2017-09-12       Impact factor: 4.333

Review 7.  The clinical application of high-resolution peripheral computed tomography (HR-pQCT) in adults: state of the art and future directions.

Authors:  J P van den Bergh; P Szulc; A M Cheung; M Bouxsein; K Engelke; R Chapurlat
Journal:  Osteoporos Int       Date:  2021-05-22       Impact factor: 4.507

8.  A tissue-selective estrogen complex as treatment of osteoporosis in experimental lupus.

Authors:  Jauquline Nordqvist; Cecilia Engdahl; Julia M Scheffler; Priti Gupta; Karin L Gustafsson; Marie K Lagerquist; Hans Carlsten; Ulrika Islander
Journal:  Lupus       Date:  2022-01-21       Impact factor: 2.911

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.